Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

India Globalization Capital Inc (NY: IGC )

0.8700 USD +0.0200 (+2.35%)
Official Closing Price Updated: 8:00 PM EST, Jan 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 206,581
Open 0.8300
Bid (Size) 0.8800 (1)
Ask (Size) 0.9000 (76)
Prev. Close 0.8500
Today's Range 0.8200 - 0.9000
52wk Range 0.7900 - 4.650
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors
IGC Appoints Former Congressman Jim Moran to its Board of Directors. 
From Business Wire News Releases
Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug
Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug 
From Business Wire News Releases

Performance

YTD
-16.35%
-16.35%
1 Month
-13.86%
-13.86%
3 Month
-37.86%
-37.86%
6 Month
-50.85%
-50.85%
1 Year
-45.28%
-45.28%

More News

Read More
Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients
From Business Wire News Releases
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients
From Business Wire News Releases
IGC Reports Financial Results for the September 30, 2021 Quarter
From Business Wire News Releases
IGC Announces Results of its 2021 Annual Stockholders Meeting
From Business Wire News Releases
IGC THC-Drug For Alzheimer's Symptoms Proved Safe & Effective, Pending FDA Approval For More Trials
Tags News Benzinga Cannabis
From Benzinga
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
From Business Wire News Releases
IGC Trials Research Effective THC Drug Dosing For Alzheimer's Patients
Tags Cannabis THC/drug for Alzheimer's symptoms Benzinga
From Benzinga
IGC Reports Financial Results for the June 30, 2021, Quarter
From Business Wire News Releases
Potential Cannabis Unicorn "InterCure" Realizes the 7th Consecutive Quarter of Revenue Growth
Tags Benzinga Cannabis Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.